Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...
Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...
At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...
A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...
This session examines the current state of progress toward a functional cure for HIV, drawing on advances in immunology, ...
Rakhants’a’s mother died when he was very young, leaving his grandmother to raise him. In 2007, when he was just 4 years old, ...
The “enormous revelation” that drugs can be used to prevent catching HIV has benefitted millions and helped slash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback